Cancer Research UK logo.
SearchDonate
  • Search

A trial of atezolizumab and trastuzumab emtansine for breast cancer (ASTEFANIA)

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at atezolizumab with trastuzumab emtansine after surgery to remove breast cancer.

It is for people with breast cancer that has a large number of the protein (HER2 positive).

Recruitment start: 7 May 2021

Recruitment end: 31 July 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Duncan Wheatley

Supported by

Roche

Last reviewed: 21 Nov 2024

CRUK internal database number: 17462

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.